Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization

被引:40
作者
Edelman, K [1 ]
Malmström, K
He, Q
Savolainen, J
Terho, EO
Mertsola, J
机构
[1] Turku Univ Hosp, Dept Paediat, FIN-20520 Turku, Finland
[2] Turku Univ, Dept Pulm Dis & Clin Allergol, Turku, Finland
[3] Turku Univ, Med Res Lab, Turku, Finland
[4] Natl Publ Hlth Inst, Turku, Finland
基金
芬兰科学院;
关键词
pertussis; pertussis toxin; acellular DTP vaccine; diphtheria; tetanus;
D O I
10.1007/s004310051264
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Local reactions and pertussis toxin specific immunoglobulin E antibodies (PT-IgE) were investigated in healthy children following primary and booster immunization with a combined diphtheria tetanus acellular pertussis vaccine (DTPa) including pertussis toxin, filamentous haemagglutinin and pertactin. A primary series of DTPa was administered to 150 infants, and 104 of them received a booster dose of DTPa combined with inactivated polio vaccine at 2 years of age. PT-ISE was measured in serum samples from 72 children using a modified nitrocellulose RAST. Primary immunization was associated with low incidence of local reactions (1%-5%). After the booster dose 21% of children had a local reaction greater than or equal to 20 mm. Local reactions after the booster dose tended to be more common in children who had experienced reaction at primary immunization. PT-IgE was detected in 18% and 86% of children following primary and booster vaccinations, respectively. Allergic and non-allergic children did not differ in PT-IgE responses. After primary immunization, elevated PT-IgE levels were found more often in children with a family history of allergy than in those without known allergy in the family. Children with local reactions had significantly higher pre- and post-booster PT-IgE levels and median post-booster pertactin IgG and diphtheria-IgG levels than children without local reactions. Conclusion Acellular pertussis immunization induces IgE antibodies to pertussis toxin, especially after booster vaccination. The higher median pre- and post-booster levels of pertussis toxin specific immunoglobulin E and post-booster levels of IgG to pertactin and diphtheria in children with local side-effects reflect a multifactorial immunological mechanism of such reactions.
引用
收藏
页码:989 / 994
页数:6
相关论文
共 34 条
[1]   IGE ANTIBODIES TO TETANUS TOXOID IN RELATION TO ATOPY [J].
AALBERSE, RC ;
VANREE, R ;
DANNEMAN, A ;
WAHN, U .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) :169-171
[2]   Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States [J].
Bernstein, HH ;
Rothstein, EP ;
Pichichero, ME ;
Green, JL ;
Reisinger, KS ;
Blatter, MM ;
Halpern, J ;
Arbeter, AM ;
Bernstein, DI ;
Smith, V ;
Long, SS ;
Rathfon, H ;
Krause, DS .
VACCINE, 1995, 13 (17) :1631-1635
[3]  
BLENNOW M, 1988, PEDIATRICS, V82, P293
[4]  
BLENNOW M, 1989, PEDIATRICS, V84, P62
[5]  
DECKER MD, 1995, PEDIATRICS, V96, P557
[6]  
DELORIA MA, 1995, PEDIATRICS, V96, P592
[7]   Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines [J].
Duchen, K ;
Granstrom, M ;
Hedenskog, S ;
Blennow, M ;
Bjorksten, B .
VACCINE, 1997, 15 (14) :1558-1561
[8]  
GIFFORD CG, 1985, ANN ALLERGY, V54, P483
[9]   A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis [J].
Greco, D ;
Salmaso, S ;
Mastrantonio, P ;
Giuliano, M ;
Tozzi, AE ;
Anemona, A ;
Atti, MLCD ;
Giammanco, A ;
Panei, P ;
Blackwelder, WC ;
Klein, DL ;
Wassilak, SGF ;
Stefanelli, P ;
Bottone, M ;
Sofia, T ;
Luzi, S ;
Bellomi, G ;
Cobianchi, F ;
Canganella, G ;
Meduri, F ;
Scuderi, G ;
Chiarini, A ;
Maggio, M ;
Taormina, S ;
Genovese, M ;
Moiraghi, A ;
Barale, A ;
DiTommaso, S ;
Malaspina, S ;
Vasile, E ;
Ferraro, P ;
DalLago, P ;
DeMarzi, L ;
Robino, L ;
Giraldo, E ;
Coppola, N ;
Materassi, P ;
Castellani, GT ;
Basso, F ;
Barbuti, S ;
Quarto, M ;
Lopalco, P ;
DOrazio, P ;
Sanguedolce, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :341-348
[10]   A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].
Gustafsson, L ;
Hallander, HO ;
Olin, P ;
Reizenstein, E ;
Storsaeter, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355